Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial (2019)
- Authors:
- Burt, Richard K.
- Balabanov, Roumen
- Burman, Joachim
- Sharrack, Basil
- Snowden, John A.
- Oliveira, Maria Carolina
- Fagius, Jan
- Rose, John
- Nelson, Flavia
- Barreira, Amilton Antunes
- Carlson, Kristina
- Han, Xiaoqiang
- Moraes, Daniela
- Morgan, Amy
- Quigley, Kathleen
- Yaung, Kimberly
- Buckley, Regan
- Alldredge, Carri
- Clendenan, Allison
- Calvario, Michelle A.
- Henry, Jacquelyn
- Jovanovic, Borko
- Helenowski, Irene B.
- Burt, Richard K.
- USP affiliated authors: RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP ; BARREIRA, AMILTON ANTUNES - FMRP
- Unidade: FMRP
- DOI: 10.1001/jama.2018.18743
- Subjects: CÉLULAS-TRONCO; ESCLEROSE MÚLTIPLA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BURT, Richard K. et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Jama, v. 321, n. 2, p. 165-174, 2019Tradução . . Disponível em: https://doi.org/10.1001/jama.2018.18743. Acesso em: 14 fev. 2026. -
APA
Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., et al. (2019). Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Jama, 321( 2), 165-174. doi:10.1001/jama.2018.18743 -
NLM
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial [Internet]. Jama. 2019 ; 321( 2): 165-174.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1001/jama.2018.18743 -
Vancouver
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial [Internet]. Jama. 2019 ; 321( 2): 165-174.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1001/jama.2018.18743 - The innate and adaptive immunological aspects in neurodegenerative diseases
- Transplante de células-tronco hematopoéticas para doenças auto-imunes graves e refratárias ao tratamento convencional
- Praticidade feminina na terapia celular. [Depoimento a Rosemeire Soares Talamone]
- New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis
- Haematopoietic stem cell transplantation in autoimmune diseases: from basic science to clinical practice
- Avaliação dos fatores genéticos, clínicos e imunológicos relacionados à independência de insulina exógena pos-transplante autólogo de células tronco hematopoiéticas no diabetes melito do tipo 1
- Cardiac assessment before stem cell transplantation for systemic sclerosis. [Carta]
- Caracterização de pacientes com esclerose sistêmica atendidos no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-Universidade de São Paulo
- Blogs cannot separate wheat from chaff. [Carta]
- Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners
Informações sobre o DOI: 10.1001/jama.2018.18743 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003005062.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
